Health plan paid cost of epilepsy in 2009 in the U.S.

Epilepsy and Behavior

Volumn 25, Issue 3, 2012, Pages 412-416

  Wilner, Andrew N ^a   Sharma, Bal K ^b   Soucy, Alison ^b   Krueger, Andrew ^b  

^a Lawrence and Memorial Hospital   (United States)

^b CVS Caremark   (United States)

Author keywords

Cost driver; Disease cost; Epilepsy; Health care costs; Incremental cost; Seizures

Indexed keywords

ADULT; ARTICLE; EPILEPSY; FEMALE; GENDER; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; SCORING SYSTEM; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; COSTS AND COST ANALYSIS; EPILEPSY; FEMALE; HEALTH CARE COSTS; HEALTH PLANNING; HUMANS; MALE; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 84868673711     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.08.029     Document Type: Article

References (27)

1. Yoon D., Frick K.D., Carr D.A., Austin J.K. Economic impact of epilepsy in the United States. Epilepsia 2009, 50(10):2186-2191.
2. Ivanova J.I., Birnbaum H.G., Kidolezi Y., Qiu Y., Mallett D., Caleo S. Economic burden of epilepsy among the privately insured in the US. Pharmacoeconomics 2010, 28:675-685.
3. Ivanova J.I., Birnbaum H.G., Kidolezi Y., Qiu Y., Mallett D., Caleo S. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States. Epilepsia 2010, 51:838-844.
4. Jennum P., Gyllenborg J., Kjellberg J. The social and economic consequences of epilepsy: a controlled national study. Epilepsia 2011, 52:949-959. 10.1111/j.1528-1167.2010.02946.x.
5. Begley C.E., Famulari M., Annegers J.F., et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000, 41:342-351.
6. Begley C.E., Lairson D.R., Reynolds T.F., Coan S. Early treatment cost in epilepsy and how it varies with seizure type and frequency. Epilepsy Res 2001, 47:205-215.
7. Begley C.E. Pharmacoeconomics of epilepsy treatment. Atlas of epilepsies 2010, Vol 3:1599-1633. Springer-Verlag London Limited. C.P. Panayiotopoulos (Ed.).
8. Cramer J., Blum D., Fanning K., Reed M. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004, 5:337-342.
9. Eccher M., Bengier A., Liberman J. Rates of psychiatric and medical comorbidities in patients with seizure disorder: evidence from an electronic database. Abstract presented in 2012 American Academy of Neurology annual meeting 2012, New Orleans, LA, USA 2012.
10. Kobau R., Zahran H., Thurman D.J., et al. Epilepsy surveillance among adults -19 states behavioral risk factor surveillance system. MMWR Surveill Summ 2008, 57(S06):1-20.
11. Cardarelli W.J., Smith B.J. The burden of epilepsy to patients and payers. Am J Manag Care 2010, 16:S331-S336.
12. Metcalfe A., Jette N. Medical and employment-related costs of epilepsy in the USA. Expert Rev Pharmacoecon Outcomes Res 2010, 10:645-647.
13. Engel J., Wiebe S., French J., et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy. Report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurologic Surgeons. Neurology 2003, 60:538-547.
14. Frost F.J., Hurley J.S., Petersen H.V., et al. A comparison of two methods for estimating the health care costs of epilepsy. Epilepsia 2000, 41:1020-1026.
15. Brunetti M., Pagano E., Garattini L. The economic cost of epilepsy: a review. Ital J Neurol Sci 1998, 19:116-119.
16. Strzelczyk A., Reese J.P., Dodel R., Hamer H.M. Cost of epilepsy: a systematic review. Pharmacoeconomics 2008, 26:463-476.
17. Annegers J.F., Beghi E., Begle C.E. Cost of epilepsy: contrast of methodologies in United States and European studies. Epilepsia 1999, 40(Suppl. 8):14-18.
18. Gaitatzis A., Carroll K., Majeed A., Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004, 45:1613-1622.
19. Ottman R., Lipton R.B., Ettinger A.B., et al. Comorbidities of epilepsy: results from the epilepsy comorbidities and health (EPIC) survey. Epilepsia 2011, 52:308-315.
20. Wilner A.N., Sharma B.K., Soucy A., Krueger A. Age-sex, comorbidities, and health care utilization of individuals with epilepsy insured by multiple U.S. commercial health insurance plans - a descriptive study. Abstract presented at 2012 annual meeting of American Academy of Neurology in New Orleans, LA, USA 2012.
21. Begley C.E., Beghi E., Beran R.G., et al. ILAE Commission on the Burden of Epilepsy, Subcommission on the Economic Burden of Epilepsy: final report 1998-2001. Epilepsia 2002, 43:668-673.
22. Liebson C.L., Long K.H., Maraganore D.M., et al. Direct medical costs associated with Parkinson's disease: a population-based study. Mov Disord 2006, 21:1864-1871.
23. Guptill J.T., Sharma B.K., Marano A., Soucy A., Krueger A., Sanders D.B. Estimated cost of myasthenia gravis in an insured U.S. population. Muscle Nerve 2012, 45:363-366.
24. Dietrich E.S., Demmler M., Schulgen G., et al. Nosocomial pneumonia: a cost-of-illness analysis. Infection 2002, 30:61-67.
25. Dubberke E.R., Reske K.A., Olsen M.A., McDonald M.C., Fraser V.J. Short- and long-term attributable costs of clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008, 46:496-504.
26. Wu E.Q., Patel P.A., Yu A.P., et al. Disease- related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 2008, 14:164-175.
27. Thurman D.J., Beghi E., Begley C.E., et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011, 52(Suppl. 7):2-26.